Literature DB >> 35268076

The Effect of Dietary Interventions on Hypertriglyceridemia: From Public Health to Molecular Nutrition Evidence.

Karla Paulina Luna-Castillo1, Xochitl Citlalli Olivares-Ochoa1, Rocío Guadalupe Hernández-Ruiz1, Iris Monserrat Llamas-Covarrubias1,2, Saraí Citlalic Rodríguez-Reyes1,2, Alejandra Betancourt-Núñez1, Barbara Vizmanos1,2, Erika Martínez-López1,2, José Francisco Muñoz-Valle1,3, Fabiola Márquez-Sandoval1,2, Andres López-Quintero1,2.   

Abstract

Approximately 25-50% of the population worldwide exhibits serum triglycerides (TG) (≥150 mg/dL) which are associated with an increased level of highly atherogenic remnant-like particles, non-alcoholic fatty liver disease, and pancreatitis risk. High serum TG levels could be related to cardiovascular disease, which is the most prevalent cause of mortality in Western countries. The etiology of hypertriglyceridemia (HTG) is multifactorial and can be classified as primary and secondary causes. Among the primary causes are genetic disorders. On the other hand, secondary causes of HTG comprise lifestyle factors, medical conditions, and drugs. Among lifestyle changes, adequate diets and nutrition are the initial steps to treat and prevent serum lipid alterations. Dietary intervention for HTG is recommended in order to modify the amount of macronutrients. Macronutrient distribution changes such as fat or protein, low-carbohydrate diets, and caloric restriction seem to be effective strategies in reducing TG levels. Particularly, the Mediterranean diet is the dietary pattern with the most consistent evidence for efficacy in HTG while the use of omega-3 supplements consumption is the dietary component with the highest number of randomized clinical trials (RCT) carried out with effective results on reducing TG. The aim of this review was to provide a better comprehension between human nutrition and lipid metabolism.

Entities:  

Keywords:  clinical trial; dietary interventions; hypertriglyceridemia; molecular nutrition; triglycerides

Mesh:

Substances:

Year:  2022        PMID: 35268076      PMCID: PMC8912493          DOI: 10.3390/nu14051104

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  157 in total

Review 1.  Recent advances in dietary proteins and lipid metabolism.

Authors:  Dalia El Khoury; G Harvey Anderson
Journal:  Curr Opin Lipidol       Date:  2013-06       Impact factor: 4.776

2.  RS 10767664 gene variant in Brain Derived Neurotrophic Factor (BDNF) affect metabolic changes and insulin resistance after a standard hypocaloric diet.

Authors:  Daniel Antonio de Luis; H Fernández Ovalle; O Izaola; D Primo; Rocío Aller
Journal:  J Diabetes Complications       Date:  2017-10-14       Impact factor: 2.852

3.  The effect of hesperidin supplementation on metabolic profiles in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Zahra Yari; Mina Movahedian; Hossein Imani; Seyed Moayed Alavian; Mehdi Hedayati; Azita Hekmatdoost
Journal:  Eur J Nutr       Date:  2019-12-16       Impact factor: 5.614

4.  Effect of a balanced Korean diet on metabolic risk factors among overweight/obese Korean adults: a randomized controlled trial.

Authors:  Seong-Ah Kim; Sangah Shin; Kyungho Ha; Young Hwang; Young-Hee Park; Min-Sook Kang; Hyojee Joung
Journal:  Eur J Nutr       Date:  2020-01-11       Impact factor: 5.614

5.  Common polymorphism in the cannabinoid receptor gene type 2 (CB2R) rs3123554 are associated with metabolic changes after two different hypocaloric diets with different dietary fatty profiles.

Authors:  R Aller; D Primo; O Izaola; D A de Luis
Journal:  Clin Nutr       Date:  2018-11-30       Impact factor: 7.324

Review 6.  Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.

Authors:  Lars Berglund; John D Brunzell; Anne C Goldberg; Ira J Goldberg; Frank Sacks; Mohammad Hassan Murad; Anton F H Stalenhoef
Journal:  J Clin Endocrinol Metab       Date:  2012-09       Impact factor: 5.958

7.  A nutritive dose of pure (-)-epicatechin does not beneficially affect increased cardiometabolic risk factors in overweight-to-obese adults-a randomized, placebo-controlled, double-blind crossover study.

Authors:  Natalie Kirch; Lea Berk; Yvonne Liegl; Marcel Adelsbach; Benno F Zimmermann; Peter Stehle; Birgit Stoffel-Wagner; Norbert Ludwig; Andreas Schieber; Hans-Peter Helfrich; Sabine Ellinger
Journal:  Am J Clin Nutr       Date:  2018-06-01       Impact factor: 7.045

8.  Effects of green tea on insulin sensitivity, lipid profile and expression of PPARalpha and PPARgamma and their target genes in obese dogs.

Authors:  Samuel Serisier; Veronique Leray; Wilfried Poudroux; Thierry Magot; Khadija Ouguerram; Patrick Nguyen
Journal:  Br J Nutr       Date:  2007-12-06       Impact factor: 3.718

9.  Impact of a Usual Serving Size of Flavanol-Rich Cocoa Powder Ingested with a Diabetic-Suitable Meal on Postprandial Cardiometabolic Parameters in Type 2 Diabetics-A Randomized, Placebo-Controlled, Double-Blind Crossover Study.

Authors:  Janina Rynarzewski; Lisa Dicks; Benno F Zimmermann; Birgit Stoffel-Wagner; Norbert Ludwig; Hans-Peter Helfrich; Sabine Ellinger
Journal:  Nutrients       Date:  2019-02-16       Impact factor: 5.717

10.  Two apples a day lower serum cholesterol and improve cardiometabolic biomarkers in mildly hypercholesterolemic adults: a randomized, controlled, crossover trial.

Authors:  Athanasios Koutsos; Samantha Riccadonna; Maria M Ulaszewska; Pietro Franceschi; Kajetan Trošt; Amanda Galvin; Tanya Braune; Francesca Fava; Daniele Perenzoni; Fulvio Mattivi; Kieran M Tuohy; Julie A Lovegrove
Journal:  Am J Clin Nutr       Date:  2020-02-01       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.